Concepedia

Liansheng Gong

LG

Statistics

Publications

19

Citations

612

H-Index

16

Active since

2004

Affiliations

Xiangya Hospital Central South University(Current)

Central South University

Third Xiangya Hospital

University of Rochester Medical Center

Liansheng Gong is an author at Xiangya Hospital Central South University specializing in oncology, molecular oncology, and medicine.

Publications per year

2004–2021

19

Publications

19

Galangin (GG) combined with cisplatin (DDP) to suppress human lung cancer by inhibition of STAT3-regulated NF-κB and Bcl-2/Bax signaling pathways

Shuo Yu, Liansheng Gong, Nianfeng Li et al. · Biomedicine & Pharmacotherapy · 2017 · 97 citations

Medicine, Oncology, Pharmacology +15

Androgen receptor (AR)/miR-520f-3p/SOX9 signaling is involved in altering hepatocellular carcinoma (HCC) cell sensitivity to the Sorafenib therapy under hypoxia via increasing cancer stem cells phenotype

Yao Xiao, Yin Sun, Guodong Liu et al. · Cancer Letters · 2018 · 66 citations

Medicine, Molecular Biology, Oncology +17

Secretion of interleukin-6 by bone marrow mesenchymal stem cells promotes metastasis in hepatocellular carcinoma

Fei Mi, Liansheng Gong · Bioscience Reports · 2017 · 61 citations · Full text

Medicine, Cancer Biology, Oncology +16

Increased expression of microRNA-335 predicts a favorable prognosis in primary gallbladder carcinoma

Yang Zhang, Honghua Peng, Zhang Yang-de et al. · OncoTargets and Therapy · 2013 · 52 citations · Full text

Medicine, Oncology, Pathology +17

MiR-590-3p suppresses hepatocellular carcinoma growth by targeting TEAD1

Xin Ge, Liansheng Gong · Tumor Biology · 2017 · 50 citations · Full text

Medicine, Cancer Biology, Oncology +16

1–5 of 19